Harvest Fund Management Co. Ltd Buys 1,512 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Harvest Fund Management Co. Ltd boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 49.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,593 shares of the medical equipment provider’s stock after acquiring an additional 1,512 shares during the period. Harvest Fund Management Co. Ltd’s holdings in Intuitive Surgical were worth $1,544,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA boosted its stake in Intuitive Surgical by 0.3% during the 4th quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 8,899 shares of the medical equipment provider’s stock valued at $3,002,000 after purchasing an additional 27 shares during the last quarter. Liberty Capital Management Inc. boosted its stake in Intuitive Surgical by 3.8% during the 4th quarter. Liberty Capital Management Inc. now owns 815 shares of the medical equipment provider’s stock valued at $275,000 after purchasing an additional 30 shares during the last quarter. Miracle Mile Advisors LLC boosted its stake in shares of Intuitive Surgical by 2.3% in the 4th quarter. Miracle Mile Advisors LLC now owns 1,438 shares of the medical equipment provider’s stock worth $485,000 after buying an additional 32 shares during the last quarter. Ausdal Financial Partners Inc. boosted its stake in shares of Intuitive Surgical by 1.5% in the 4th quarter. Ausdal Financial Partners Inc. now owns 2,192 shares of the medical equipment provider’s stock worth $739,000 after buying an additional 33 shares during the last quarter. Finally, Venturi Wealth Management LLC boosted its stake in shares of Intuitive Surgical by 10.7% in the 4th quarter. Venturi Wealth Management LLC now owns 341 shares of the medical equipment provider’s stock worth $115,000 after buying an additional 33 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 2.2 %

Shares of Intuitive Surgical stock traded up $8.15 during trading on Tuesday, hitting $377.08. The stock had a trading volume of 1,836,588 shares, compared to its average volume of 1,677,112. The firm has a market cap of $133.66 billion, a price-to-earnings ratio of 68.07, a P/E/G ratio of 5.69 and a beta of 1.36. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $403.76. The business’s 50-day moving average is $386.54 and its 200 day moving average is $344.98.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.10. The firm had revenue of $1.89 billion for the quarter, compared to analysts’ expectations of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The business’s quarterly revenue was up 11.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.00 earnings per share. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 4.93 EPS for the current year.

Insider Transactions at Intuitive Surgical

In related news, VP Fredrik Widman sold 5,041 shares of the stock in a transaction on Friday, March 15th. The stock was sold at an average price of $397.07, for a total value of $2,001,629.87. Following the transaction, the vice president now owns 110 shares of the company’s stock, valued at $43,677.70. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In related news, VP Fredrik Widman sold 5,041 shares of the stock in a transaction on Friday, March 15th. The stock was sold at an average price of $397.07, for a total value of $2,001,629.87. Following the transaction, the vice president now owns 110 shares of the company’s stock, valued at $43,677.70. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Mark Brosius sold 196 shares of the stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $400.00, for a total value of $78,400.00. Following the completion of the transaction, the senior vice president now directly owns 1,842 shares in the company, valued at approximately $736,800. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 248,418 shares of company stock valued at $95,927,097. 0.80% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on ISRG. Robert W. Baird cut their target price on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a research note on Friday. BTIG Research boosted their target price on Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a research note on Friday. Citigroup boosted their target price on Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. Raymond James boosted their target price on Intuitive Surgical from $372.00 to $435.00 and gave the stock an “outperform” rating in a research note on Thursday, January 25th. Finally, Mizuho upped their price objective on Intuitive Surgical from $350.00 to $390.00 and gave the company a “neutral” rating in a research note on Thursday, January 25th. Five investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $396.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.